Massachusetts General Hospital (MGH) — Boston, Massachusetts

Massachusetts General Hospital (MGH) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital (MGH) has participated in 28 clinical trials with 11 currently active.

Therapeutic areas: Glioblastoma, Paroxysmal Atrial Fibrillation, Sexual Dysfunction.

Sponsors: Philogen S.p.A., Boston Scientific Corporation, Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital (MGH)?

Massachusetts General Hospital (MGH) has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital (MGH) conducted?

Massachusetts General Hospital (MGH) has 28 clinical trials on record, with 11 currently active. Their work covers Glioblastoma, Paroxysmal Atrial Fibrillation, Sexual Dysfunction.

Is Massachusetts General Hospital (MGH) accredited by Crixeo Health?

Yes — Massachusetts General Hospital (MGH) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Massachusetts General Hospital (MGH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.